Literature DB >> 3022680

Involvement of actin-containing microfilaments in HSV-induced cytopathology and the influence of inhibitors of glycosylation.

U Heeg, H P Dienes, S Müller, D Falke.   

Abstract

Two and a half hours after infection with a high dose of different strains of HSV-1 which induce rounding of cells, breakdown of actin containing microfilaments can be observed. At the periphery of the cell, actin containing knob-like protuberances were visible. Later on, actin seems to be located exclusively on the surface of cells. Observations were done by immunofluorescence microscopy, scanning electron-microscopy and immunoperoxidase staining of ultrathin sections. The envelope of HSV appears to be stained by anti-actin. Strain IES produces rounding of cells at a high dose of infection before fusion proceeds at 37 degrees C. Similar alterations were not observed with the fusing strains MP and HFEM. Incubation of infected cells at 39 degrees C revealed strain dependent differences of the fusion activity. At 41 degrees C no "fusion from within" of cells but only rounding was detectable. Application of tunicamycin resulted in complete inhibition of fusion by all strains. The fusion activity of some strains of HSV-1 (ANG, HFEM, and MP) was not inhibited by addition of 2-deoxy-D-glucose and 2-fluoro-deoxy-D-glucose. A variant from strain MP could be isolated, which is sensitive to the effects of 2-deoxy-D-glucose. Inhibitors of processing of glycoproteins did not affect fusion of cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3022680     DOI: 10.1007/bf01314285

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  29 in total

1.  Polykaryocytosis.

Authors:  B ROIZMAN
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

2.  Timing of some of the molecular events required for cell fusion induced by herpes simplex virus type 1.

Authors:  K G Kousoulas; S Person; T C Holland
Journal:  J Virol       Date:  1978-09       Impact factor: 5.103

3.  Effect of 2-deoxy-D-glucose on cell fusion induced by Newcastle disease and herpes simplex viruses.

Authors:  W R Gallaher; D B Levitan; H A Blough
Journal:  Virology       Date:  1973-09       Impact factor: 3.616

4.  A monoclonal antibody recognizes an epitope common to an avian-specific nuclear antigen and to cytokeratins.

Authors:  R M Franklin; L R Emmons; R P Emmons; O Kai; A Oommen; J R Pink; A M Rijnbeek; M Schnetzler; L Tuderman; E Vainio
Journal:  J Cell Biochem       Date:  1984       Impact factor: 4.429

5.  Effect of tunicamycin on the synthesis of herpes simplex virus type 1 glycoproteins and their expression on the cell surface.

Authors:  B Norrild; B Pedersen
Journal:  J Virol       Date:  1982-08       Impact factor: 5.103

6.  Fine mapping of mutations in the fusion-inducing MP strain of herpes simplex virus type 1.

Authors:  K L Pogue-Geile; G T Lee; S K Shapira; P G Spear
Journal:  Virology       Date:  1984-07-15       Impact factor: 3.616

7.  Early changes in the distribution and organization of microfilament proteins during cell transformation.

Authors:  C B Boschek; B M Jockusch; R R Friis; R Back; E Grundmann; H Bauer
Journal:  Cell       Date:  1981-04       Impact factor: 41.582

8.  Dependence of herpes simplex virus type 1-induced cell fusion on cell type.

Authors:  D J Bzik; S Person
Journal:  Virology       Date:  1981-04-15       Impact factor: 3.616

9.  Fluorosugars inhibit biological properties of different enveloped viruses.

Authors:  M F Schmidt; R T Schwarz; H Ludwig
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

10.  N-methyl-1-deoxynojirimycin, a novel inhibitor of glycoprotein processing, and its effect on fowl plague virus maturation.

Authors:  P A Romero; R Datema; R T Schwarz
Journal:  Virology       Date:  1983-10-15       Impact factor: 3.616

View more
  12 in total

1.  Characterization of a recombinant herpes simplex virus which expresses a glycoprotein D lacking asparagine-linked oligosaccharides.

Authors:  D L Sodora; R J Eisenberg; G H Cohen
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Replication of herpes simplex virus: egress of progeny virus at specialized cell membrane sites.

Authors:  Rebecca M Mingo; Jun Han; William W Newcomb; Jay C Brown
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

3.  Characterization of fusion from without induced by herpes simplex virus.

Authors:  I Walev; K C Wollert; K Weise; D Falke
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

4.  Microtubules and intermediate filaments of herpes simplex virus infected cells.

Authors:  H P Dienes; G Hiller; S Müller; D Falke
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  The nectin-1alpha transmembrane domain, but not the cytoplasmic tail, influences cell fusion induced by HSV-1 glycoproteins.

Authors:  Ravi P Subramanian; Jennifer E Dunn; Robert J Geraghty
Journal:  Virology       Date:  2005-09-01       Impact factor: 3.616

6.  Accumulation of herpes simplex virus type 1 early and leaky-late proteins correlates with apoptosis prevention in infected human HEp-2 cells.

Authors:  M Aubert; S A Rice; J A Blaho
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1.

Authors:  M Aubert; J O'Toole; J A Blaho
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

8.  Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes.

Authors:  Karen E Johnson; Leela Chikoti; Bala Chandran
Journal:  J Virol       Date:  2013-02-20       Impact factor: 5.103

9.  Herpes simplex virus type 1 immediate-early gene expression is required for the induction of apoptosis in human epithelial HEp-2 cells.

Authors:  Christine M Sanfilippo; Fungai N W Chirimuuta; John A Blaho
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1.

Authors:  P A Johnson; A Miyanohara; F Levine; T Cahill; T Friedmann
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.